Evidence and Guidance of Hepatitis C Therapy in Pregnancy – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“Hepatitis C remains a massive public health problem, but promise has arrived in direct-acting antivirals (DAAs).
In this review, the authors review the state of the evidence regarding hepatitis C therapy in pregnancy, arriving at a conclusion that while larger prospective trials are being conducted, shared-decision making for HepC therapy in pregnancy should be considered given the potential for pregnancy as a major window to combatting this infection. They also provide guidance on counseling about therapy, open registries, and ongoing trials.”
Title: Hepatitis C Treatment During Pregnancy: Time for a Practice Change
Authors: Karley Dutra, Jonathan M. Fenkel
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 31, 2026, 17:24Riikka Leppänen: Happy to Attend the Nordic Fertility Society Congress 2026
-
Aug 31, 2026, 17:18Brian A. Levine: The Question of Whether to Try Again is One of The Hardest in Medicine
-
Aug 31, 2026, 17:13Aumatma Simmons: Trying to Conceive Can Feel Like a Full-Time Job…
-
Aug 31, 2026, 17:11Nalanda Jayadev: What if “Knowing Early” Could “Change” a Child’s Future?
-
Aug 31, 2026, 17:04Oluyemisi Famuyiwa: Your Fertility Story Should Begin with Knowledge, Not a Crisis
-
Aug 31, 2026, 17:01Vasileios Sarafis: The S.A.F.A.R.I. Protocol – 6 Domains, 1 Structured Plan
-
Aug 31, 2026, 16:54Amitha Nanjundaiah: Should We Aim for Better Oocyte Quality or Greater Oocyte Numbers?
-
Aug 31, 2026, 16:51Sahana C: In Fertility, the Messiness of Clinical Analytics Is Real
-
Aug 31, 2026, 16:46Elham Mohammadzadeh: Attending Excellent Scientific Sessions at NFS 2026